Abstract
MELODI (Multidisciplinary European Low Dose Initiative) is a European radiation protection research platform with focus
on research on health risks after exposure to low-dose ionising radiation. It was founded in 2010 and currently includes 44
members from 18 countries. A major activity of MELODI is the continuous development of a long-term European Strategic
Research Agenda (SRA) on low-dose risk for radiation protection. The SRA is intended to identify priorities for national
and European radiation protection research programs as a basis for the preparation of competitive calls at the European level.
Among those key priorities is the improvement of health risk estimates for exposures close to the dose limits for workers
and to reference levels for the population in emergency situations. Another activity of MELODI is to ensure the availability
of European key infrastructures for research activities, and the long-term maintenance of competences in radiation research
via an integrated European approach for training and education. The MELODI SRA identifies three key research topics in
low dose or low dose-rate radiation risk research: (1) dose and dose rate dependence of cancer risk, (2) radiation-induced
non-cancer effects and (3) individual radiation sensitivity. The research required to improve the evidence base for each of
the three key topics relates to three research lines: (1) research to improve understanding of the mechanisms contributing to
radiogenic diseases, (2) epidemiological research to improve health risk evaluation of radiation exposure and (3) research to
address the effects and risks associated with internal exposures, differing radiation qualities and inhomogeneous exposures.
The full SRA and associated documents can be downloaded from the MELODI website (http://www.melodi-online.eu/sra.
html).
Original language | English |
---|---|
Number of pages | 11 |
Journal | Radiation and Environmental Biophysics |
Volume | 57 |
Issue number | 5 |
DOIs | |
State | Published - 15 Dec 2017 |